Ramazan Duz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramazan Duz has a total of 301 co-authors. Here are the top co-authors by number of shared publications:
- Ferit Böyük
Department of Cardiology, Kanuni Sultan Süleyman Training and Research Hospital, Health Science University, İstanbul 34303, Türkiye
4 shared publications - Lütfü Bekar
Department of Cardiology, Faculty of Medicine, Hitit University, Çorum 19030, Türkiye
4 shared publications - Ayşegül Ülgen Kunak
Department of Cardiology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Türkiye
3 shared publications - Ertan Aydın
Department of Cardiology, Faculty of Medicine, Giresun University, Giresun, Turkey
3 shared publications - Mehdi Zoghi
Department of Cardiology, Faculty of Medicine, Ege University, İzmir 35040, Türkiye
3 shared publications - Mehmet Kış
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, 35340 İzmir, Turkey
3 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6047
Blood Pressure and Angina-Related Health Status During Benidipine Therapy: A Multicenter Real-World Cohort Study
Background: Benidipine is a long-acting calcium channel blocker used for the treatment of hypertension and chronic coronary syndrome. Although it effectively lowers blood pressure (BP), the relationship between BP reduction and improvement in angina-related health status during benidipine therapy remains uncertain. This study evaluated changes in BP and patient-reported angina-related health status in a large real-world cohort. Methods: This prospective, multicenter, observational cohort study included 1659 patients with hypertension and/or chronic coronary syndrome who underwent baseline clinical assessment before initiation of benidipine therapy and were reassessed after 3 months. Changes in systolic and diastolic BP and Seattle Angina Questionnaire-7 (SAQ-7) scores were evaluated. Multivariable linear regression analyses were performed to identify predictors of BP reduction and symptomatic improvement. A propensity score-matched analysis according to coronary artery disease (CAD) status was conducted to further explore differences in treatment response. Results: The mean age was 62.2 ± 12.2 years, and 54.0% of participants were women. Systolic BP decreased by 13.8 mmHg and diastolic BP by 6.7 mmHg (both p < 0.001). Mean SAQ-7 score increased by 8.1 points (p < 0.001), exceeding the established threshold for clinically meaningful improvement. Baseline SAQ-7 score showed the strongest association with change in SAQ-7, whereas baseline systolic BP was the strongest predictor of BP reduction. The correlation between changes in systolic BP and SAQ-7 was weak (r = 0.058, p = 0.023). In the propensity score-matched cohort (n = 732), BP reduction was similar regardless of CAD status, whereas improvement in SAQ-7 was greater in patients without obstructive CAD. Conclusions: In this multicenter real-world cohort, benidipine therapy was associated with significant BP reduction and clinically meaningful improvement in angina-related health status over 3 months. Symptomatic improvement showed only a weak association with BP reduction. These findings should be interpreted within the limitations of an observational study and warrant confirmation in controlled comparative studies.
- 4 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6047
Open AccessBlood Pressure and Angina-Related Health Status During Benidipine Therapy: A Multicenter Real-World Cohort Study
Background: Benidipine is a long-acting calcium channel blocker used for the treatment of hypertension and chronic coronary syndrome. Although it effectively lowers blood pressure (BP), the relationship between BP reduction and improvement in angina-related health status during benidipine therapy remains uncertain. This study evaluated changes in BP and patient-reported angina-related health status in a large real-world cohort. Methods: This prospective, multicenter, observational cohort study included 1659 patients with hypertension and/or chronic coronary syndrome who underwent baseline clinical assessment before initiation of benidipine therapy and were reassessed after 3 months. Changes in systolic and diastolic BP and Seattle Angina Questionnaire-7 (SAQ-7) scores were evaluated. Multivariable linear regression analyses were performed to identify predictors of BP reduction and symptomatic improvement. A propensity score-matched analysis according to coronary artery disease (CAD) status was conducted to further explore differences in treatment response. Results: The mean age was 62.2 ± 12.2 years, and 54.0% of participants were women. Systolic BP decreased by 13.8 mmHg and diastolic BP by 6.7 mmHg (both p < 0.001). Mean SAQ-7 score increased by 8.1 points (p < 0.001), exceeding the established threshold for clinically meaningful improvement. Baseline SAQ-7 score showed the strongest association with change in SAQ-7, whereas baseline systolic BP was the strongest predictor of BP reduction. The correlation between changes in systolic BP and SAQ-7 was weak (r = 0.058, p = 0.023). In the propensity score-matched cohort (n = 732), BP reduction was similar regardless of CAD status, whereas improvement in SAQ-7 was greater in patients without obstructive CAD. Conclusions: In this multicenter real-world cohort, benidipine therapy was associated with significant BP reduction and clinically meaningful improvement in angina-related health status over 3 months. Symptomatic improvement showed only a weak association with BP reduction. These findings should be interpreted within the limitations of an observational study and warrant confirmation in controlled comparative studies.
- Open Access
- 30 June 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1489
Redox Imbalance and Coronary Complexity Linking Oxidative Stress Biomarkers to SYNTAX II Score in Acute Coronary Syndrome
Background: Lipoprotein metabolism, inflammation, and oxidative stress (OS) play interconnected roles in the pathogenesis of acute coronary syndrome (ACS). However, the relationship between oxidative stress biomarkers and coronary artery disease (CAD) complexity, particularly as assessed by the SYNTAX II score, remains incompletely understood. This study aimed to evaluate serum levels of oxidative stress–related biomarkers and to investigate their association with the SYNTAX II score in patients with newly diagnosed ACS. Methods: This was a retrospective, single-center observational study. A total of 60 patients with newly diagnosed ACS who underwent percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) were consecutively enrolled. Serum levels of superoxide dismutase (SOD), advanced oxidation protein products (AOPP), glutathione, catalase, and malondialdehyde (MDA) were measured using ELISA methods. Associations between oxidative stress markers and the SYNTAX II score were analyzed using correlation and regression analyses. Results: Median levels of SOD, AOPP, and glutathione were 261.0 (244.18–324.86) U/L, 23.81 (22.62–25.80) ng/mL, and 6.08 (5.28–11.46) ng/mL, respectively. Mean catalase and MDA levels were 339.07 ± 44.81 pg/mL and 0.66 ± 0.07 mmol/L. The SYNTAX II score was positively correlated with SOD, AOPP, glutathione, catalase, and MDA, as well as with age, female sex, and potassium levels, while it was negatively correlated with hemoglobin, creatinine clearance, and left ventricular ejection fraction (all p < 0.05). Patients with higher SYNTAX II scores demonstrated elevated levels of both oxidant and antioxidant biomarkers. Conclusions: Oxidative stress-related biomarkers were associated with the SYNTAX II score in patients with newly diagnosed ACS.
- 30 June 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1489
Open AccessRedox Imbalance and Coronary Complexity Linking Oxidative Stress Biomarkers to SYNTAX II Score in Acute Coronary Syndrome
Background: Lipoprotein metabolism, inflammation, and oxidative stress (OS) play interconnected roles in the pathogenesis of acute coronary syndrome (ACS). However, the relationship between oxidative stress biomarkers and coronary artery disease (CAD) complexity, particularly as assessed by the SYNTAX II score, remains incompletely understood. This study aimed to evaluate serum levels of oxidative stress–related biomarkers and to investigate their association with the SYNTAX II score in patients with newly diagnosed ACS. Methods: This was a retrospective, single-center observational study. A total of 60 patients with newly diagnosed ACS who underwent percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) were consecutively enrolled. Serum levels of superoxide dismutase (SOD), advanced oxidation protein products (AOPP), glutathione, catalase, and malondialdehyde (MDA) were measured using ELISA methods. Associations between oxidative stress markers and the SYNTAX II score were analyzed using correlation and regression analyses. Results: Median levels of SOD, AOPP, and glutathione were 261.0 (244.18–324.86) U/L, 23.81 (22.62–25.80) ng/mL, and 6.08 (5.28–11.46) ng/mL, respectively. Mean catalase and MDA levels were 339.07 ± 44.81 pg/mL and 0.66 ± 0.07 mmol/L. The SYNTAX II score was positively correlated with SOD, AOPP, glutathione, catalase, and MDA, as well as with age, female sex, and potassium levels, while it was negatively correlated with hemoglobin, creatinine clearance, and left ventricular ejection fraction (all p < 0.05). Patients with higher SYNTAX II scores demonstrated elevated levels of both oxidant and antioxidant biomarkers. Conclusions: Oxidative stress-related biomarkers were associated with the SYNTAX II score in patients with newly diagnosed ACS.
- Open Access
- 30 August 2024
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 17 (2) , 76-80
Fibromiyalji Hastalarındaki Anksiyete/Depresyon ile Maksimal Oksijen Tüketimi Arasındaki İlişki
Amaç: Bu çalışmadaki amacımız; Fibromiyalji Sendromu (FMS) hastalarında, önce hastalığa eşlik etmesi beklenen anksiyete ve depresyon ile ilgili hasta şikayetlerini ve egzersiz yaptıkları sıradaki maksimal oksijen kullanma kapasiteleri üzerinden egzersiz toleranslarını belirlemeye çalışmak ve ardından en yüksek oksijen tüketimi ile anksiyete ve depresyon skorları arasındaki ilişkiyi gösterebilmektir. Materyal ve Metot: Erişkin (18-65 yaş aralığında) bireyler iki gruba ayrılarak; birinci gruba (n=30) FMS tanılı hastalar, ikinci gruba (n=30) ise benzer yaş ve aynı cinsiyet özelliğinde bulunan fiziksel ve psikiyatrik muyaeneleri doğal olan sağlıklı kontrol grubu bireyler dahil edilmiştir. Her iki gruptaki hastalara aynı kontrolde önce ondört sorudan oluşan ‘Hastane anksiyete ve depresyon (HAD) ölçeği’ uygulanıp, sonrasında VO2 max (egzersiz sırasında tüketilen en yüksek oksijen miktarı) değeri ölçülmüştür. Bulgular: HAD skor ortalaması hasta grubunda (23.23), kontrol grubu (5.63) ile karşılaştırıldığında, istatistiksel olarak anlamlı şekilde daha yüksekti (p=0.001). VO2 max değer ortalaması hasta grubunda (21.70 ml / kg / dak), kontrol grubu ile karşılaştırıldığında (34.30 ml / kg / dak), istatistiksel olarak anlamlı şekilde daha düşüktü (p=0.001). Hasta grubunda, HAD skoru arttıkça VO2 max değerlerinin anlamlı düzeyde daha düşük ölçüldüğü gözlenmiştir (r= -0.507 ve p= 0.043). Sonuç: Depresyon ve anksiyete bulguları FMS hastalarına kontrol grubuna göre daha fazla eşlik etmiştir. Egzersiz sırasındaki maksimal oksijen tüketimi FMS hastalarında kontrol grubuna göre daha kötü olarak ölçülmüştür. FMS hastalarında depresyon ve anksiyete bulguları arttıkça, maksimal oksijen tüketimi de anlamlı düzeyde bozulmuştur Anahtar Kelimeler: fibromiyalji, anksiyete, depresyon, oksijen tüketimi, vo2 max
- 30 August 2024
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 17 (2) , 76-80
Open AccessFibromiyalji Hastalarındaki Anksiyete/Depresyon ile Maksimal Oksijen Tüketimi Arasındaki İlişki
Amaç: Bu çalışmadaki amacımız; Fibromiyalji Sendromu (FMS) hastalarında, önce hastalığa eşlik etmesi beklenen anksiyete ve depresyon ile ilgili hasta şikayetlerini ve egzersiz yaptıkları sıradaki maksimal oksijen kullanma kapasiteleri üzerinden egzersiz toleranslarını belirlemeye çalışmak ve ardından en yüksek oksijen tüketimi ile anksiyete ve depresyon skorları arasındaki ilişkiyi gösterebilmektir. Materyal ve Metot: Erişkin (18-65 yaş aralığında) bireyler iki gruba ayrılarak; birinci gruba (n=30) FMS tanılı hastalar, ikinci gruba (n=30) ise benzer yaş ve aynı cinsiyet özelliğinde bulunan fiziksel ve psikiyatrik muyaeneleri doğal olan sağlıklı kontrol grubu bireyler dahil edilmiştir. Her iki gruptaki hastalara aynı kontrolde önce ondört sorudan oluşan ‘Hastane anksiyete ve depresyon (HAD) ölçeği’ uygulanıp, sonrasında VO2 max (egzersiz sırasında tüketilen en yüksek oksijen miktarı) değeri ölçülmüştür. Bulgular: HAD skor ortalaması hasta grubunda (23.23), kontrol grubu (5.63) ile karşılaştırıldığında, istatistiksel olarak anlamlı şekilde daha yüksekti (p=0.001). VO2 max değer ortalaması hasta grubunda (21.70 ml / kg / dak), kontrol grubu ile karşılaştırıldığında (34.30 ml / kg / dak), istatistiksel olarak anlamlı şekilde daha düşüktü (p=0.001). Hasta grubunda, HAD skoru arttıkça VO2 max değerlerinin anlamlı düzeyde daha düşük ölçüldüğü gözlenmiştir (r= -0.507 ve p= 0.043). Sonuç: Depresyon ve anksiyete bulguları FMS hastalarına kontrol grubuna göre daha fazla eşlik etmiştir. Egzersiz sırasındaki maksimal oksijen tüketimi FMS hastalarında kontrol grubuna göre daha kötü olarak ölçülmüştür. FMS hastalarında depresyon ve anksiyete bulguları arttıkça, maksimal oksijen tüketimi de anlamlı düzeyde bozulmuştur Anahtar Kelimeler: fibromiyalji, anksiyete, depresyon, oksijen tüketimi, vo2 max
- 6 August 2024
- Published by Academician Publishing
- p. 337-342
Karotid Baroreseptör Stimülasyonu
- Open Access
- 6 August 2024
- Published by Academician Publishing
İmplante Edilebilir Kardiyak Elektronik Cihazlar
Kardiyak Pace Tipi ve Pacing Modları Gamze Yeter ARSLAN Kalıcı Kalp Pili Endikasyonları Yusuf HOŞOĞLU Ayşe HOŞOĞLU Pacemaker & ICD İmplantasyonu Yakup YİĞİT Leadless Pacemaker Yusuf Ziya ŞENER Geçici Transvenöz Pacing ve Komplikasyonları Didar Elif AKGUN Yavuz Selim AKGUN Primer Koruma Amaçlı İmplante Edilebilir Kardiyoverter Defibrilatör Tarık YILDIRIM Sekonder Profilaksi Amaçlı İmplante Edilebilir Kardiyoverter Defibrilatör Seda Elçim YILDIRIM İmplante Edilebilir Kardiyoverter-Defibrilatör Programlama Arzu YAZAR İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Mevcut Hastalarda Uygun Cihaz Şoklarının Yönetimi Neşri DANIŞMAN Şeyhmus KULAHCIOĞLU Uygunsuz İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Şokları ve Yönetimi Onur ALTINKAYA Subkutan ICD Ertan AYDIN Giyilebilir Kardiyak Defibrilatör Abdullah SARIHAN Lütfü BEKAR Genetik Testler Selahattin AKYOL Holter Ritim Monitörizasyonu Sinem ÖZBAY ÖZYILMAZ İmplante Edilebilir Loop Recorder Hatice TAŞKAN Tilt Table Testi Güney SARIOĞLU Pacemaker ve ICD Endikasyonu Belirlemede Kullanılan Testler-Kardiyak Görüntüleme (EKO ve MRG) Emirhan ÇAKIR Elektrofizyolojik Çalışma Muhammed Kemal KAHYALAR Kalp Yetersizliği Tedavisinde Kardiyak Resenkronizasyon Tedavisi Enfal ÇAKMAK AKSU Fatih AKKAYA Kardiyak Resenkronizasyon Tedavisi Endikasyonları ve Hasta Seçimi Tayfur ERDOĞDU Koroner Sinüs Anatomisi ve KRT Doğan İLİŞ KRT İmplantasyonu Kubilay ERSELCAN Cerrahi KRT İmplantasyonu Mahmut YARGI Kime KRT-D & Kime KRT-P Fahri CAKAN Kardiyak Resenkronizasyon Tedavisi Yanıt Tanımı ve İlişkili Faktörler Lütfü AŞKIN Elektrokardiyografi ve Ekokardiyografi ile Kardiyak Resenkronizasyon Tedavisi Optimizasyonu Şerif HAMİDEYİN Kardiyak Resenkronizasyon Tedavisi Programlama Fatih KÖKSAL Diyafragma Pacingi Yönetimi Emre ASİLTÜRK Atriyal Fibrilasyonda Atrioventriküler (AV) Nod Ablasyonu ve Kardiyak Resenkronizasyon Tedavisi Halil İbrahim DURMUŞ HİS-Demeti Pacing Ayça ARSLAN Sol Dal Pacing İnanç ARTAÇ HİS Optimize Kardiyak Resenkranizasyon Tedavisi Süleyman BARUTCU Sol Dal Optimize Kardiyak Resenkronizasyon Tedavisi Hakan Gökalp UZUN Jeneratör Replasmanı Yusuf Bozkurt ŞAHİN Lead Ekstraksiyonu Nihan BAHADIR Kardiyak İmplante Edilebilir Elektronik Cihazların (KİEC) İmplantasyonu Sonrası Takip Şeyhmus Erkan DEMİRCAN Baver EKİNCİ Atrial Yüksek Hız Epizot Yönetimi Muhammet GENEŞ Kardiyak İmplante Edilebilir Cihazlarda Telekardiyografik Değerlendirme Zelal TAHAOĞLU Pil Cebi Hematomu Sidar Şiyar AYDIN Pnömotoraks, Hemotoraks ve Brakiyal Pleksus Yaralanması Ali Nail KAYA Kardiyak İmplante Edilebilir Elektronik Cihazların Komplikasyonu Kardiyak Rüptür/Perikardiyal Efüzyon Burcu KODAL Lead Kusurları Mert Pehlivan ALTIN Lead Dislokasyonu Sendromları Vedat CİCEK Samet YAVUZ Lead İlişkili Triküspit Yetmezliği Timor OMAR Pacemaker Aracılı Taşikardi Lütfullah CANDAN Pacemaker Sendromu Murat KARACAM Gülümser Sevgin HALİL Oversense Sendromları Selahattin AYDIN Kardiyak İmplante Edilebilir Cihaz Enfeksiyonu Mürsel ŞAHİN Kiec İlişkili Lead Trombüsü ve Pulmoner Embolizm Emre YILMAZ Karotid Baroreseptör Stimülasyonu Fehmi ESER Ramazan DUZ Kardiyak Kontraktilite Modülasyonu Sümeyye Fatma ÖZER Pulmoner Arter Basıncı Monitorizasyonu Muammer KARAKAYALI Kardiyak İmplante Edilebilir Elektronik Cihaz İmplantasyon Sürecinde Antikoagülan Tedavi ve Antibiyotik Proflaksisi Ömer ŞİT Preoperatif Kardiyak İmplante Edilebilen Cihaz Ayarlama Ferit BÖYÜK Radyoterapi Sürecinde Kalp Pili & ICD Takibi Yusuf Ziya ŞENER Kardiyak İmplante Edilebilir Elektronik Cihazı Olan Hastada Manyetik Rezonans Görüntüleme Semih KALKAN Kalp Pili & İmplante Edilebilir Kardiyak Defibrilatör (ICD) Olan Hastalarda Spor Aktivitesi ve Sürücülük Ahmet Lütfü SERTDEMİR Ahmet Taha ŞAHİN LVAD İmplantasyonu Yapılan Hastada ICD Endikasyonu ve Yönetimi Berhan KESKİN Kardiyak Cerrahi Sonrası Pacing Muhammed Bahadır OMAR TAVİ Sonrası Pacemaker İmplantasyonu Mehmet KIŞ Çisem OKTAY Konjenital Kalp Hastalıklarında Kardiyak Pacing ve ICD Mücahit TAN Naci BABAT Sarkoidoz Kardiyak Pacing ve ICD Ercan CEĞİLLİ Pakize SUCU Kardiyak Amiloidozda Kardiyak Pacing ve ICD Onur ASLAN Hipertrofik Kardiyomiyopatide Kardiyak Pacing ve ICD Burcu OZYAZGAN Nadir Kardiyak Hastalıklarda Kardiyak Pacing ve ICD Songül USALP
- 6 August 2024
- Published by Academician Publishing
Open Accessİmplante Edilebilir Kardiyak Elektronik Cihazlar
Kardiyak Pace Tipi ve Pacing Modları Gamze Yeter ARSLAN Kalıcı Kalp Pili Endikasyonları Yusuf HOŞOĞLU Ayşe HOŞOĞLU Pacemaker & ICD İmplantasyonu Yakup YİĞİT Leadless Pacemaker Yusuf Ziya ŞENER Geçici Transvenöz Pacing ve Komplikasyonları Didar Elif AKGUN Yavuz Selim AKGUN Primer Koruma Amaçlı İmplante Edilebilir Kardiyoverter Defibrilatör Tarık YILDIRIM Sekonder Profilaksi Amaçlı İmplante Edilebilir Kardiyoverter Defibrilatör Seda Elçim YILDIRIM İmplante Edilebilir Kardiyoverter-Defibrilatör Programlama Arzu YAZAR İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Mevcut Hastalarda Uygun Cihaz Şoklarının Yönetimi Neşri DANIŞMAN Şeyhmus KULAHCIOĞLU Uygunsuz İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Şokları ve Yönetimi Onur ALTINKAYA Subkutan ICD Ertan AYDIN Giyilebilir Kardiyak Defibrilatör Abdullah SARIHAN Lütfü BEKAR Genetik Testler Selahattin AKYOL Holter Ritim Monitörizasyonu Sinem ÖZBAY ÖZYILMAZ İmplante Edilebilir Loop Recorder Hatice TAŞKAN Tilt Table Testi Güney SARIOĞLU Pacemaker ve ICD Endikasyonu Belirlemede Kullanılan Testler-Kardiyak Görüntüleme (EKO ve MRG) Emirhan ÇAKIR Elektrofizyolojik Çalışma Muhammed Kemal KAHYALAR Kalp Yetersizliği Tedavisinde Kardiyak Resenkronizasyon Tedavisi Enfal ÇAKMAK AKSU Fatih AKKAYA Kardiyak Resenkronizasyon Tedavisi Endikasyonları ve Hasta Seçimi Tayfur ERDOĞDU Koroner Sinüs Anatomisi ve KRT Doğan İLİŞ KRT İmplantasyonu Kubilay ERSELCAN Cerrahi KRT İmplantasyonu Mahmut YARGI Kime KRT-D & Kime KRT-P Fahri CAKAN Kardiyak Resenkronizasyon Tedavisi Yanıt Tanımı ve İlişkili Faktörler Lütfü AŞKIN Elektrokardiyografi ve Ekokardiyografi ile Kardiyak Resenkronizasyon Tedavisi Optimizasyonu Şerif HAMİDEYİN Kardiyak Resenkronizasyon Tedavisi Programlama Fatih KÖKSAL Diyafragma Pacingi Yönetimi Emre ASİLTÜRK Atriyal Fibrilasyonda Atrioventriküler (AV) Nod Ablasyonu ve Kardiyak Resenkronizasyon Tedavisi Halil İbrahim DURMUŞ HİS-Demeti Pacing Ayça ARSLAN Sol Dal Pacing İnanç ARTAÇ HİS Optimize Kardiyak Resenkranizasyon Tedavisi Süleyman BARUTCU Sol Dal Optimize Kardiyak Resenkronizasyon Tedavisi Hakan Gökalp UZUN Jeneratör Replasmanı Yusuf Bozkurt ŞAHİN Lead Ekstraksiyonu Nihan BAHADIR Kardiyak İmplante Edilebilir Elektronik Cihazların (KİEC) İmplantasyonu Sonrası Takip Şeyhmus Erkan DEMİRCAN Baver EKİNCİ Atrial Yüksek Hız Epizot Yönetimi Muhammet GENEŞ Kardiyak İmplante Edilebilir Cihazlarda Telekardiyografik Değerlendirme Zelal TAHAOĞLU Pil Cebi Hematomu Sidar Şiyar AYDIN Pnömotoraks, Hemotoraks ve Brakiyal Pleksus Yaralanması Ali Nail KAYA Kardiyak İmplante Edilebilir Elektronik Cihazların Komplikasyonu Kardiyak Rüptür/Perikardiyal Efüzyon Burcu KODAL Lead Kusurları Mert Pehlivan ALTIN Lead Dislokasyonu Sendromları Vedat CİCEK Samet YAVUZ Lead İlişkili Triküspit Yetmezliği Timor OMAR Pacemaker Aracılı Taşikardi Lütfullah CANDAN Pacemaker Sendromu Murat KARACAM Gülümser Sevgin HALİL Oversense Sendromları Selahattin AYDIN Kardiyak İmplante Edilebilir Cihaz Enfeksiyonu Mürsel ŞAHİN Kiec İlişkili Lead Trombüsü ve Pulmoner Embolizm Emre YILMAZ Karotid Baroreseptör Stimülasyonu Fehmi ESER Ramazan DUZ Kardiyak Kontraktilite Modülasyonu Sümeyye Fatma ÖZER Pulmoner Arter Basıncı Monitorizasyonu Muammer KARAKAYALI Kardiyak İmplante Edilebilir Elektronik Cihaz İmplantasyon Sürecinde Antikoagülan Tedavi ve Antibiyotik Proflaksisi Ömer ŞİT Preoperatif Kardiyak İmplante Edilebilen Cihaz Ayarlama Ferit BÖYÜK Radyoterapi Sürecinde Kalp Pili & ICD Takibi Yusuf Ziya ŞENER Kardiyak İmplante Edilebilir Elektronik Cihazı Olan Hastada Manyetik Rezonans Görüntüleme Semih KALKAN Kalp Pili & İmplante Edilebilir Kardiyak Defibrilatör (ICD) Olan Hastalarda Spor Aktivitesi ve Sürücülük Ahmet Lütfü SERTDEMİR Ahmet Taha ŞAHİN LVAD İmplantasyonu Yapılan Hastada ICD Endikasyonu ve Yönetimi Berhan KESKİN Kardiyak Cerrahi Sonrası Pacing Muhammed Bahadır OMAR TAVİ Sonrası Pacemaker İmplantasyonu Mehmet KIŞ Çisem OKTAY Konjenital Kalp Hastalıklarında Kardiyak Pacing ve ICD Mücahit TAN Naci BABAT Sarkoidoz Kardiyak Pacing ve ICD Ercan CEĞİLLİ Pakize SUCU Kardiyak Amiloidozda Kardiyak Pacing ve ICD Onur ASLAN Hipertrofik Kardiyomiyopatide Kardiyak Pacing ve ICD Burcu OZYAZGAN Nadir Kardiyak Hastalıklarda Kardiyak Pacing ve ICD Songül USALP
- Open Access
- 29 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (13) , e37578
Echocardiographic evaluation of myocardial strain in bipolar disorder across different phases: A comparative study with healthy controls
This study aims to investigate the relationship between different phases of bipolar disorder (depressive, manic, and euthymic) and myocardial deformation, assessed by echocardiography, compared to healthy controls. It seeks to elucidate whether these phases of bipolar disorder are associated with different myocardial strain patterns, thus contributing to the understanding of cardiovascular implications in bipolar disorder. A cross-sectional design was employed at Dursun Odabaş Medical Centre, Psychiatry Clinic of Van Yüzüncü Yl University. The study enrolled 200 participants, divided into 4 groups: 50 in a depressive phase, 50 in a manic phase, 50 in an euthymic phase of bipolar disorder, and 50 healthy volunteers. Participants underwent detailed electrocardiographic and ECG evaluations, focusing on myocardial strain patterns and cardiac function. Statistical analyses, including ANOVA and chi-square tests, were used to compare the groups. Significant differences in global longitudinal strain (GLS) values were observed between the groups. The manic phase group exhibited the highest GLS (21.51), followed by the euthymic (20.75), depressive (20.25), and healthy control groups (19.0). The E/A ratio of the mitral valve also varied, with the manic group displaying the highest ratio (1.21). Other echocardiographic parameters such as left atria size and Ejection Fraction also differed significantly between the groups. The study concluded that the phases of bipolar disorder are associated with distinct myocardial strain patterns, as evidenced by the variation in GLS values. The findings underscore the importance of cardiac monitoring in bipolar disorder, suggesting potential cardiac risks, particularly during the manic phase. This study advocates integrated care approaches, combining psychiatric and cardiac evaluations for patients with bipolar disorder.
- 29 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (13) , e37578
Open AccessEchocardiographic evaluation of myocardial strain in bipolar disorder across different phases: A comparative study with healthy controls
This study aims to investigate the relationship between different phases of bipolar disorder (depressive, manic, and euthymic) and myocardial deformation, assessed by echocardiography, compared to healthy controls. It seeks to elucidate whether these phases of bipolar disorder are associated with different myocardial strain patterns, thus contributing to the understanding of cardiovascular implications in bipolar disorder. A cross-sectional design was employed at Dursun Odabaş Medical Centre, Psychiatry Clinic of Van Yüzüncü Yl University. The study enrolled 200 participants, divided into 4 groups: 50 in a depressive phase, 50 in a manic phase, 50 in an euthymic phase of bipolar disorder, and 50 healthy volunteers. Participants underwent detailed electrocardiographic and ECG evaluations, focusing on myocardial strain patterns and cardiac function. Statistical analyses, including ANOVA and chi-square tests, were used to compare the groups. Significant differences in global longitudinal strain (GLS) values were observed between the groups. The manic phase group exhibited the highest GLS (21.51), followed by the euthymic (20.75), depressive (20.25), and healthy control groups (19.0). The E/A ratio of the mitral valve also varied, with the manic group displaying the highest ratio (1.21). Other echocardiographic parameters such as left atria size and Ejection Fraction also differed significantly between the groups. The study concluded that the phases of bipolar disorder are associated with distinct myocardial strain patterns, as evidenced by the variation in GLS values. The findings underscore the importance of cardiac monitoring in bipolar disorder, suggesting potential cardiac risks, particularly during the manic phase. This study advocates integrated care approaches, combining psychiatric and cardiac evaluations for patients with bipolar disorder.
- Open Access
- 25 March 2024
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 88 (4) , 597-605
Severity of Mitral Valve Stenosis ― Possible Relationships With Blood Oxidant Markers and Antioxidants ―
Background: This study examined whether the severity of mitral valve stenosis (MVS) is associated with oxidative stress (OS) markers in the blood, and other hematological and clinicodemographic parameters.Methods and Results: This prospective study was conducted between March and May 2022. Seventy-five patients with newly diagnosed MVS (25 mild, 25 moderate, 25 severe) were included. Mild, moderate, and severe MVS was defined as MV area >2, 1.5–2, and 315.5 ng/mL) and glutathione (cut-off >4.7 μmol/L).Conclusions: MVS severity seems to be affected by oxidant markers (malondialdehyde and AOPP), antioxidant enzymes (SOD), and inflammation-related cells (WBC and platelets). Future studies are needed to examine these relationships in larger populations.
- 25 March 2024
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 88 (4) , 597-605
Open AccessSeverity of Mitral Valve Stenosis ― Possible Relationships With Blood Oxidant Markers and Antioxidants ―
Background: This study examined whether the severity of mitral valve stenosis (MVS) is associated with oxidative stress (OS) markers in the blood, and other hematological and clinicodemographic parameters.Methods and Results: This prospective study was conducted between March and May 2022. Seventy-five patients with newly diagnosed MVS (25 mild, 25 moderate, 25 severe) were included. Mild, moderate, and severe MVS was defined as MV area >2, 1.5–2, and 315.5 ng/mL) and glutathione (cut-off >4.7 μmol/L).Conclusions: MVS severity seems to be affected by oxidant markers (malondialdehyde and AOPP), antioxidant enzymes (SOD), and inflammation-related cells (WBC and platelets). Future studies are needed to examine these relationships in larger populations.
- Open Access
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (11)
Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR
Background Dual antiplatelet therapy (DAPT) is the treatment of choice for patients with acute and chronic coronary syndromes as it reduces mortality and prevents recurrent thrombotic complications. The assessment of both ischaemic burden and bleeding risk is crucial in deciding which DAPT to choose and how long it should be continued. Objectives The aim of our study was to perform prospective clinical follow-up of patients receiving fixed-dose combination therapy (ASA 75 mg + clopidogrel 75 mg). Our study is a multicentric, cross-sectional, observational, cohort study. Methods A total of 1500 patients who were started on fixed-dose combination DAPT for acute or chronic coronary syndrome were included in the study. Primary endpoints were hospitalization for any reason, hospitalization for cardiovascular cause, acute myocardial infarction, stent thrombosis, target vessel revascularization and bleeding; the secondary endpoints were death for any reason or cardiovascular cause and stroke. The significance level adopted in the statistical analysis was 5%. Results Median age was 63 years; 78.5% of the patients were receiving DAPT treatment for acute coronary syndrome. The rates of hospitalization for cardiovascular reasons, acute myocardial infartion, stent thrombosis and target-vessel revascularization were 7.9%, 2.3%, 1.3% and 4.2%, respectively. While the rate of BARC type 1 bleeding was 3.3%, the rate of BARC type 5, 3, or 2 bleeding was 0.6%. The secondary endpoints which were death from any cause, cardiovascular death and stroke were 0.5%, 0.3% and 0.3%, respectively. Conclusion: Our study shows that fixed-dose combination therapy is effective and safe in appropriately selected patients with acute or chronic coronary syndromes.
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (11)
Open AccessFixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR
Background Dual antiplatelet therapy (DAPT) is the treatment of choice for patients with acute and chronic coronary syndromes as it reduces mortality and prevents recurrent thrombotic complications. The assessment of both ischaemic burden and bleeding risk is crucial in deciding which DAPT to choose and how long it should be continued. Objectives The aim of our study was to perform prospective clinical follow-up of patients receiving fixed-dose combination therapy (ASA 75 mg + clopidogrel 75 mg). Our study is a multicentric, cross-sectional, observational, cohort study. Methods A total of 1500 patients who were started on fixed-dose combination DAPT for acute or chronic coronary syndrome were included in the study. Primary endpoints were hospitalization for any reason, hospitalization for cardiovascular cause, acute myocardial infarction, stent thrombosis, target vessel revascularization and bleeding; the secondary endpoints were death for any reason or cardiovascular cause and stroke. The significance level adopted in the statistical analysis was 5%. Results Median age was 63 years; 78.5% of the patients were receiving DAPT treatment for acute coronary syndrome. The rates of hospitalization for cardiovascular reasons, acute myocardial infartion, stent thrombosis and target-vessel revascularization were 7.9%, 2.3%, 1.3% and 4.2%, respectively. While the rate of BARC type 1 bleeding was 3.3%, the rate of BARC type 5, 3, or 2 bleeding was 0.6%. The secondary endpoints which were death from any cause, cardiovascular death and stroke were 0.5%, 0.3% and 0.3%, respectively. Conclusion: Our study shows that fixed-dose combination therapy is effective and safe in appropriately selected patients with acute or chronic coronary syndromes.
- Open Access
- 7 July 2023
- Published by Turkish Journal of Sports Medicine, Turkish Sports Medicine Association in Turkish Journal of Sports Medicine
- Vol. 58 (3) , 108-111
Impact of using surgical face masks on exercise test parameters in professional athletes
Background: The use of face masks is common worldwide due to the COVID-19 pandemic. However, the debate on the advantages and disadvantages of face masks continues. While face masks have been recommended to protect from COVID-19, their potential risks on cardiorespiratory systems in various populations are being investigated. This study aims to examine the impact of face masks on exercise test parameters in professional athletes. Mater als and Methods: 25 professional athletes (mean age: 19.6±2.4 years; F/M: 11/14; BMI: 20.2±1.6 kg/m 2) were included in the study. They performed an exercise test two times, with and without face masks, 48 hours apart. A comparison of exercise test parameters with and without face masks was made to determine cardiorespiratoryresponses in professional athletes. Results: The participants with and without face masks were statistically similar for the test parameters, excluding final oxygen saturation, test duration (min), and peak heart rate. The participants with face masks had significantly lower scores of final oxygen saturation (p<0.001), test duration (p<0.001), and peak heart rate (p=0.004) compared with the participants without face masks. Conclus on: Our results revealed that the use of face masks during the exercise test is associated with lower scores of oxygen saturation, test duration, and peak heart rate.
- 7 July 2023
- Published by Turkish Journal of Sports Medicine, Turkish Sports Medicine Association in Turkish Journal of Sports Medicine
- Vol. 58 (3) , 108-111
Open AccessImpact of using surgical face masks on exercise test parameters in professional athletes
Background: The use of face masks is common worldwide due to the COVID-19 pandemic. However, the debate on the advantages and disadvantages of face masks continues. While face masks have been recommended to protect from COVID-19, their potential risks on cardiorespiratory systems in various populations are being investigated. This study aims to examine the impact of face masks on exercise test parameters in professional athletes. Mater als and Methods: 25 professional athletes (mean age: 19.6±2.4 years; F/M: 11/14; BMI: 20.2±1.6 kg/m 2) were included in the study. They performed an exercise test two times, with and without face masks, 48 hours apart. A comparison of exercise test parameters with and without face masks was made to determine cardiorespiratoryresponses in professional athletes. Results: The participants with and without face masks were statistically similar for the test parameters, excluding final oxygen saturation, test duration (min), and peak heart rate. The participants with face masks had significantly lower scores of final oxygen saturation (p<0.001), test duration (p<0.001), and peak heart rate (p=0.004) compared with the participants without face masks. Conclus on: Our results revealed that the use of face masks during the exercise test is associated with lower scores of oxygen saturation, test duration, and peak heart rate.
- Open Access
Awareness and Knowledge of Pneumococcal Vaccination in Cardiology Outpatient Clinics and the Impact of Physicians’ Recommendations on Vaccination Rates
Aim: We aimed to evaluate the awareness of pneumococcal vaccination (PCV13, PPSV23) in general cardiology outpatient clinics and impact of physicians’ recommendations on vaccination rates. Methods: This was a multicenter, observational, prospective cohort study. Patients over the age of 18 from 40 hospitals in different regions of Turkey who applied to the cardiology outpatient clinic between September 2022 and August 2021 participated. The vaccination rates were calculated within three months of follow-up from the admitting of the patient to cardiology clinics. Results: The 403 (18.2%) patients with previous pneumococcal vaccination were excluded from the study. The mean age of study population (n = 1808) was 61.9 ± 12.1 years and 55.4% were male. The 58.7% had coronary artery disease, hypertension (74.1%) was the most common risk factor, and 32.7% of the patients had never been vaccinated although they had information about vaccination before. The main differences between vaccinated and unvaccinated patients were related to education level and ejection fraction. The physicians’ recommendations were positively correlated with vaccination intention and behavior in our participants. Multivariate logistic regression analysis showed a significant correlation between vaccination and female sex [OR = 1.55 (95% CI = 1.25–1.92), p < 0.001], higher education level [OR = 1.49 (95% CI = 1.15–1.92), p = 0.002] patients’ knowledge [OR = 1.93 (95% CI = 1.56–2.40), p < 0.001], and their physician’s recommendation [OR = 5.12 (95% CI = 1.92–13.68), p = 0.001]. Conclusion: To increase adult immunization rates, especially among those with or at risk of cardiovascular disease (CVD), it is essential to understand each of these factors. Even if during COVID-19 pandemic, there is an increased awareness about vaccination, the vaccine acceptance level is not enough, still. Further studies and interventions are needed to improve public vaccination rates.
Open AccessAwareness and Knowledge of Pneumococcal Vaccination in Cardiology Outpatient Clinics and the Impact of Physicians’ Recommendations on Vaccination Rates
Aim: We aimed to evaluate the awareness of pneumococcal vaccination (PCV13, PPSV23) in general cardiology outpatient clinics and impact of physicians’ recommendations on vaccination rates. Methods: This was a multicenter, observational, prospective cohort study. Patients over the age of 18 from 40 hospitals in different regions of Turkey who applied to the cardiology outpatient clinic between September 2022 and August 2021 participated. The vaccination rates were calculated within three months of follow-up from the admitting of the patient to cardiology clinics. Results: The 403 (18.2%) patients with previous pneumococcal vaccination were excluded from the study. The mean age of study population (n = 1808) was 61.9 ± 12.1 years and 55.4% were male. The 58.7% had coronary artery disease, hypertension (74.1%) was the most common risk factor, and 32.7% of the patients had never been vaccinated although they had information about vaccination before. The main differences between vaccinated and unvaccinated patients were related to education level and ejection fraction. The physicians’ recommendations were positively correlated with vaccination intention and behavior in our participants. Multivariate logistic regression analysis showed a significant correlation between vaccination and female sex [OR = 1.55 (95% CI = 1.25–1.92), p < 0.001], higher education level [OR = 1.49 (95% CI = 1.15–1.92), p = 0.002] patients’ knowledge [OR = 1.93 (95% CI = 1.56–2.40), p < 0.001], and their physician’s recommendation [OR = 5.12 (95% CI = 1.92–13.68), p = 0.001]. Conclusion: To increase adult immunization rates, especially among those with or at risk of cardiovascular disease (CVD), it is essential to understand each of these factors. Even if during COVID-19 pandemic, there is an increased awareness about vaccination, the vaccine acceptance level is not enough, still. Further studies and interventions are needed to improve public vaccination rates.